BioSpace News Archive

Sun Genomics, the direct-to-consumer custom probiotics and gut health company, announces the launch of its at-home Floré Labs COVID-19 Stool Test, available this week, to identify whether an individual has viral shedding of the SARS-CoV-2 Virus and therefore risk long hauler symptoms or potentially contagious.

Opti N ose , Inc. (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the company has granted non-qualified stock option awards to purchase an aggregate of 35,000 shares of its common stock to two new employees as an inducement material to them accepting employment with OptiNose. The stock option awards were approved by the Compensation Committee of the

Sentient Decision Science, a leading provider of Emotional Intelligence for business, today announced the United States Patent and Trademark Office (USPTO) has issued Notice of Allowance for a patent on the implicit association technology powering Sentient Prime.

Harmonic Bionics , Inc. announced today that they will be partnering with Korean-based H Robotics , Inc. to assist with the US distribution of rebless™, a smart rehabilitation device and recent recipient of a CES 2021 Innovation Award in the Health and Wellness category. rebless™ is an FDA-registered robotic, exercise the

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), today announced that the first patient has been dosed in the phase 3 LIGHTHOUSE study, evaluating the efficacy and safety of a triple combination therapy with melflufen plus dexamethasone and subcutaneous daratumumab compared to daratumumab alone. The phase 3 LIGHTHOUSE study is a random

Triangle Orthopaedics Surgery Center announces the achievement of AAAHC Advanced Orthopaedic Certification by the Accreditation Association for Ambulatory Health Care (AAAHC). Certification i

OrthoGrid® Systems, Inc., a global medtech leader on a mission to digitally transform intraoperative musculoskeletal surgery, announces the publication of new clinical data supporting the use of its analog and digital technology in the Journal of Arthroplasty (JOA).

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that abstracts detailing new interim results from its ABO-102 Phase 1/2 Transpher A study for MPS IIIA and ABO-101 Phase 1/2 Transpher B study for MPS IIIB have been accepted for platform oral presentations during the late-breaking abstract session at the 17 th Annual WORLD Symposium ™ being held February 8-12, 2021. “Children

Concert Genetics today unveiled the Concert Genetics Benefit Program, an end-to-end genetic testing management solution that enables health plans to provide members with access to high-quality, clinically appropriate genetic testing while improving payment integrity and reducing manual work.

The Somatic Experiencing ® Trauma Institute (SE Institute) and Therapy Aid Coalition (TAC) today announced that the two organizations are collaborating to provide meaningful mental health and wellness resources to frontline workers and emergency responders affected by the coronavirus pandemic